Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dennis Christensen. (2016) Vaccine adjuvants: Why and how. Human Vaccines & Immunotherapeutics 12:10, pages 2709-2711.
Read now
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now
Read now
Nathalie Garçon, David W Vaughn & Arnaud M Didierlaurent. (2012) Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion. Expert Review of Vaccines 11:3, pages 349-366.
Read now
Read now
Nikolai Petrovsky & Dimitar Sajkov. (2011) Pediatric influenza immunization. Expert Review of Vaccines 10:5, pages 567-570.
Read now
Read now
Articles from other publishers (24)
Elias Tjärnhage, Diamond Brown, Bjarne Bogen, Tor Kristian Andersen & Gunnveig Grødeland. (2023) Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza. Journal of Virology 97:2.
Crossref
Crossref
Yucheol Cheong, Minjin Kim, Jina Ahn, Hana Oh, Jongkwan Lim, Wonil Chae, Seung Won Yang, Min Seok Kim, Ji Eun Yu, Sanguine Byun, Yo Han Jang & Baik Lin Seong. (2021) Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Frontiers in Immunology 12.
Crossref
Crossref
Jingdi Pan & Zongqiang Cui. (2020) Self‐Assembled Nanoparticles: Exciting Platforms for Vaccination. Biotechnology Journal 15:12, pages 2000087.
Crossref
Crossref
Peter L. Stern. (2020) Key steps in vaccine development. Annals of Allergy, Asthma & Immunology 125:1, pages 17-27.
Crossref
Crossref
Anna Kazakova, Laura Kakkola, Thedi Ziegler, Ritva Syrjänen, Henna Päkkilä, Matti Waris, Tero Soukka & Ilkka Julkunen. (2020) Pandemic influenza A(H1N1pdm09) vaccine induced high levels of influenza-specific IgG and IgM antibodies as analyzed by enzyme immunoassay and dual-mode multiplex microarray immunoassay methods. Vaccine 38:8, pages 1933-1942.
Crossref
Crossref
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest & Lutz Nuhn. (2018) Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 289, pages 125-145.
Crossref
Crossref
Reshma J. Nevagi, Istvan Toth & Mariusz Skwarczynski. 2018. Peptide Applications in Biomedicine, Biotechnology and Bioengineering. Peptide Applications in Biomedicine, Biotechnology and Bioengineering
327
358
.
Ailian Zhang, Danyang Wang, Jinyao Li, Feng Gao & Xucheng Fan. (2017) The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity. PLOS ONE 12:8, pages e0183720.
Crossref
Crossref
Tülin Morçӧl, Brett L. Hurst & E. Bart Tarbet. (2017) Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice. Vaccine 35:35, pages 4569-4577.
Crossref
Crossref
Patricia Izurieta, Mercy Jeane Uy-Aragon, Mamadou Dramé & David W. Vaughn. (2016) Assessment of Prime-boost Vaccination Using an AS03B-adjuvanted Influenza A (H5N1) Vaccine. Pediatric Infectious Disease Journal 35:2, pages e35-e47.
Crossref
Crossref
Birgit Weinberger, Clemens Joos, Steven G. Reed, Rhea Coler & Beatrix Grubeck-Loebenstein. (2015) The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age. Biogerontology 17:1, pages 177-187.
Crossref
Crossref
Lawrence Segal, Virginie Roger, Colin Williams, Eric Destexhe & Nathalie Garçon. (2015) Effects of Adjuvant Systems on the cardiovascular and respiratory functions in telemetered conscious dogs and anaesthetised rats. Regulatory Toxicology and Pharmacology 73:1, pages 116-125.
Crossref
Crossref
Rie S. Kallerup & Camilla Foged. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
15
29
.
Ritva K. Syrjänen, Jukka Jokinen, Thedi Ziegler, Jonas Sundman, Mika Lahdenkari, Ilkka Julkunen & Terhi M. Kilpi. (2014) Effectiveness of Pandemic and Seasonal Influenza Vaccines in Preventing Laboratory-Confirmed Influenza in Adults: A Clinical Cohort Study during Epidemic Seasons 2009–2010 and 2010–2011 in Finland. PLoS ONE 9:9, pages e108538.
Crossref
Crossref
Charlotte I S Barker & Matthew D Snape. (2014) Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action. The Lancet Infectious Diseases 14:3, pages 227-238.
Crossref
Crossref
Vinay Rambal, Karin Müller, Chantip Dang-Heine, Arne Sattler, Mikalai Dziubianau, Benjamin Weist, Si-Hong Luu, Alexandra Stoyanova, Peter Nickel, Andreas Thiel, Avidan Neumann, Brunhilde Schweiger, Petra Reinke & Nina Babel. (2013) Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients. Medical Microbiology and Immunology 203:1, pages 35-45.
Crossref
Crossref
Johan Berglund, Peter Vink, Fernanda Tavares Da Silva, Pascal Lestrate & Dominique Boutriau. (2014) Safety, Immunogenicity, and Antibody Persistence following an Investigational Streptococcus pneumoniae and Haemophilus influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults. Clinical and Vaccine Immunology 21:1, pages 56-65.
Crossref
Crossref
Odile Launay, Xavier Duval, Serge Fitoussi, Wolfgang Jilg, Angkool Kerdpanich, May Montellano, Tino F Schwarz, Veerachai Watanveerade, Jürgen J Wenzel, Gerard Zalcman, Vinod Bambure, Ping Li, Adrian Caplanusi, Anuradha Madan, Paul Gillard & David W Vaughn. (2013) Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials. BMC Infectious Diseases 13:1.
Crossref
Crossref
Darren R. Flower. 2013. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines. Immunomic Discovery of Adjuvants and Candidate Subunit Vaccines
155
180
.
Andreas Mörner, Andreas Bråve, Anna-Maria Kling, Sharon Kühlmann-Berenzon, Katarina Krook, Mona Hedenskog, Irene Silhammar, Margaretha Ljungman, Åke Örtqvist, Sören Andersson, Maria Brytting, Rigmor Thorstensson & Annika Linde. (2012) Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009. PLoS ONE 7:12, pages e53511.
Crossref
Crossref
Alina Isai, Julie Durand, Steven Le Meur, Ana Hidalgo-Simon & Xavier Kurz. (2012) Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review. Vaccine 30:49, pages 7123-7129.
Crossref
Crossref
Tina Schmidt, Jan Dirks, Martin Enders, Barbara C. Gärtner, Heike Uhlmann‐Schiffler, Urban Sester & Martina Sester. (2012)
CD
4
+
T
‐cell immunity after pandemic influenza vaccination cross‐reacts with seasonal antigens and functionally differs from active influenza infection
. European Journal of Immunology 42:7, pages 1755-1766.
Crossref
Crossref
Andrew J Broadbent & Kanta Subbarao. (2011) Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Current Opinion in Virology 1:4, pages 254-262.
Crossref
Crossref
Camilla Foged. (2011) Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Therapeutic Delivery 2:8, pages 1057-1077.
Crossref
Crossref